SLNO icon

Soleno Therapeutics

12 hedge funds and large institutions have $11.7M invested in Soleno Therapeutics in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 4 closing their positions.

Holders
12
Holders Change
Holders Change %
0%
% of All Funds
0.3%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
6
Increased
5
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
VC
1
Vivo Capital
California
$10.4M 14,695,264 +7,238,280 +97%
Deutsche Bank
2
Deutsche Bank
Germany
$408K 575,184 +325,184 +130%
PAI
3
Palo Alto Investors
California
$301K 423,738 +423,738 New
BG
4
Bollard Group
Massachusetts
$259K 365,316 -17,310 -5%
SM
5
Sabby Management
Florida
$159K 233,938 +54,936 +31%
BlackRock
6
BlackRock
New York
$54K 77,088 +77,088 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$46K 67,770 +5,700 +9%
Goldman Sachs
8
Goldman Sachs
New York
$21K 28,939 +4,925 +21%
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$20K 29,700 +29,700 New
Citadel Advisors
10
Citadel Advisors
Florida
$17K 24,525 +24,525 New
Northern Trust
11
Northern Trust
Illinois
$10K 14,376 +14,376 New
Morgan Stanley
12
Morgan Stanley
New York
$1K 1,400 +1,400 New
AFM
13
Anson Funds Management
Texas
-355,497 Closed
TSS
14
Two Sigma Securities
New York
-15,189 Closed
UBS Group
15
UBS Group
Switzerland
-5,588 Closed
Bank of America
16
Bank of America
North Carolina
-56 Closed